Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
The Food and Drug Administration has authorized Novavax s booster shots which were designed to fight the wild type Covid strain. Anyone 12 and older will be eligible.
Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
WASHINGTON (dpa-AFX) - Novavax, Inc. (NVAX) reported data from the phase 3 PREVENT-19 trial and Study 307. PREVENT-19 data in both adults aged 18 and older and adolescents aged 12 through 17 showed